All posts by medical

What Birds Do for Us and What We Can Do for Them – The New York Times

This spring, the dawn chorus sounds different. In the dark hours before sunrise, my yard whistles, chips, hoots, and trills with deafening birdsong. The birds caroling at my home in Virginia robins, mockingbirds, warblers, cardinals, titmice, finches sound more numerous, boisterous and energetic than in past years, all singing raucously at the same time, like a poetry slam where everyones reading at once.

Have the lockdowns resulted in more abundant birds? Is our behavior changing theirs, making them bolder, louder, more present in our yards and parks, or is the birdsong just more audible because theres less ambient roar from cars, overhead jets, construction?

Or is it we who have changed, taking more notice of bird life now that our own lives have slowed?

The studies arent in on the impact of shifting human patterns on bird activity during the pandemic. It will most likely take years before we have firm data. But the anecdotes, from all around the world, are intriguing. My friends in Australia and New Zealand tell me that since the lockdowns began, flocks of spine-tailed swifts have swelled, more fairy-wrens are popping up at their bird baths and kereru big pigeons that swallow large fruit are perching on their back fences. The lack of people is indeed being noticed by the wildlife, said Darryl Jones, an ecologist at Griffith University specializing in the interaction between humans and wildlife. He points to the pair of very rare glossy black cockatoos that showed up on the vacant Griffith campus near Brisbane, along with more than 50 koalas in the nearby forest.

When the lockdowns were in full force, birds appeared to be thriving with the dip in noise and light and air pollution, along with emptied-out parks and public gardens that are usually a crush of people and traffic congestion. Here in the United States, ravens normally on edge around their nests in Yosemite were more relaxed, even playful in the empty parking lots, and endangered piping plovers had the beaches to themselves. One friend of mine from New York wrote to say, There seem to be birds everywhere in the city, more than usual, having parties in the bushes, quarreling, singing.

Roadkills have most likely been down, the naturalist and conservationist Kenn Kaufman told me. In open country, they have not been happening at nearly the same rate, he said, sparing roadside species like meadowlarks and redheaded woodpeckers. There have also been far fewer bird strikes by airplanes, decreasing kills of kestrels, killdeer and other species.

The reduction in noise may have a more subtle but still beneficial effect. Birds sing in the early morning to mark their territory and attract mates. Their efforts, however, often coincide with the roar of early morning rush hour. A few years ago, scientists from the University of Florida found that noisy highways prevented tufted titmice and northern cardinals from hearing alarm calls from fellow birds, warning of dangerous predators in the area, putting them at greater risk of becoming prey.

Now that things are opening up, all of this may be changing. Those ravens in Yosemite parking lots and shorebirds nesting on once empty beaches must now contend with returning crowds. The human din is beginning again.

The more enduring change may be in human behavior around birds. At the moment, most serious bird-watchers are not sashaying out to distant locations to spot a vagrant species or catch the big waves of migratory species passing through, but rather, observing more birdlife close to home. The American Bird Association, which calls the shots on ethical birding, advises: Keep your eyes on the skies but your butt close to home. And at least for now, thats what most birders are doing (including Christian Cooper, whose experience safely birding in peace in Central Park was stolen from him).

Mr. Kaufman laments missing his regular visits to Magee Marsh Wildlife Area in Ohio, a famous hot spot for spring migration on the edge of Lake Erie, still rightly closed to the public. Ordinarily at this season we would be going a few times per week to see water birds like herons, grebes, and coots, he says. At the waters edge, long-distance migrant shorebirds like pectoral sandpipers, lesser yellowlegs, and American golden-plovers would be showing up, coming from South America, gradually making their way to nesting grounds on Arctic tundra. Back in the woods, the first wave of songbird migrants would be pumping in: fox sparrows, purple finches, rusty blackbirds, hermit thrushes, lots of golden-crowned kinglets.

But, he says, he really cant complain. Hes just focusing more on the birds in the habitat of his yard. There was a fox sparrow here the other day one of my favorite birds. It felt like a blessing.

A lot of us, even those of us who arent hard-core birders, are turning more toward our yards and gardens, noting birds and bird activities weve never seen before not because theyre new, necessarily, but because weve just never paid such close attention. One neighbor walking her dog remarked that shes seeing more of spring than ever. I just saw an early indigo bunting flying through our yard, wrote a friend. Ordinarily they dont love my neighborhood and especially our overgrown yard, so I am ecstatic.

With any luck, this human shift may stick: People noticing the birds around them more and finding entertainment, solace, even wisdom in watching them going about their lives in a regular way, finding mates, building nests, raising young, resilient and persistent. Birds may have something important to tell us about what it takes to navigate this world, especially under difficult circumstances. In exploring new discoveries in bird science, Im struck by how birds play, adapt, innovate, and especially, work together in tough times. Birds cooperate and collaborate in everything from hunting, courting, and migrating, to raising and defending their young, sometimes even across species lines.

While the pandemic may have brought birds into closer focus for many of us, it has also given our current administration cover for rolling back vital environmental policies that protect birds, easing limits on auto emissions, restricting the reach of the Endangered Species Act and eviscerating the Migratory Bird Treaty Act. Ending the five-decade-old practice of pressuring industries to take measures to prevent unintentional killing (or incidental take) of migratory birds is likely to result in the catastrophic death of hundreds of millions of birds every year. The long-term impact of all of these changes will harm both birds and people.

We want to return to our lives and livelihoods, but not by sacrificing the natural world that supports us in body and in spirit. One older bird-watcher I know described the effect of seeing a bluebird in his urban backyard during the lockdown, for only the third time in sixteen years. The aura of it was bigger than the essence, the cold hard fact, of it, he said. A bluebird on my backyard fence is just a bird sitting on a piece of metal. But what it does to me is so much more, the emotional and psychological uplift, the brightening. In three minutes, the bird was gone, but my day had utterly changed.

Jennifer Ackerman (@JenGAckerman) is the author, most recently, of The Bird Way: A New Look at How Birds Talk, Work, Play, Parent, and Think.

Visit link:
What Birds Do for Us and What We Can Do for Them - The New York Times

MBA after BCom; subject combo with maths; and scope in biochemistry – The Tribune

Will MBA after Bcom improve my career prospects?

Q. What are my career options if I pursue MCom instead of MBA after completing BCom?

Megha Bisht

A. While an MBA is a professional, job-oriented PG programme in management, an MCom is somewhat more academic & theoretical in content and approach.

After completing your MCom, the main avenues open to you those in Teaching, Accounting & Audit, Taxation, Finance, and Banking.

By adding a BEd to your MCom youll be eligible to teach Commerce at the Plus II level. And if you clear the NET exam, you can even teach at the college level.

MCom graduates can find suitable openings in financial research and analysis, taxation, stock market, insurance, financial planning and advisory, banking, financial services sales in all kinds of financial product and service providers besides those in accounting, financial processing/modeling and documentation as well as in KPOs.

You can sit for general competitive entrance exams such as the Civil Services or State Selection Commission. Your MCom qualification will also allow you to take the selection exams for the Income Tax, Customs and Excise Departments, Comptroller & Auditor General, Bank Probationary Officers.

Which subject combinations are available with maths in Class XI?

Q. I am in Class X. I am confused about choosing a subject next year. I want to pursue maths, but I do not know which other subjects I can take along with it. Can you help me with this?

Arvind Kumar

A. There are three streams in which you can take maths:

Career opportunities are truly wide and varied for anyone who has a talent and passion for mathematics. No wonder its called the queen of sciences!

Whats more, mathematics is not just for mathematicians. The skills you develop while studying for a math degree such as the ability to think logically as well as in abstraction find valuable and multifaceted applications in virtually every walk of life.

Some of the areas where number-crunchers are particularly valued are in: investment banking, insurance companies (Actuaries), taxation, engineering consulting, medical research, bioinformatics, computer science, computer security, data science and Big data, defense, operations research, market research (specifically quantitative) and media planning.

Going places with BSc biochem

Q. I had PCB in Class XII, but I am not very hopeful of clearing the NEET. I am interested in joining BSc biochemistry in DU. Apart from research and lectureship, what other career options can I go for?

Arun Shukla

A. Though personally I think you should give NEET a shot and have a positive attitude about your performance, it is good that you have a plan B in place. And it is a good plan as biochemists are playing an increasingly significant role in biological, environmental and clinical fields, with employment areas stretching from health care to agriculture. Biochemical analysis is used in clinical and forensic science (e.g. DNA fingerprinting) and in the food and pharmaceutical industries. Growth areas, where recruitment is intense, include biotechnology and bioinformatics.

Employment prospects for Biochemists with a master's degree are on the rise. While some go on to pursue research and further study, the rest find employment in industry, Pharma, education and related areas.

Of course, you are free to look at other options in life sciences and healthcare industry or anything else for that matter at the PG level. All the best!

Originally posted here:
MBA after BCom; subject combo with maths; and scope in biochemistry - The Tribune

Former UT walk-on linebacker recalls juggling band practice, and biochemistry – San Antonio Express-News

AUSTIN Some nights, Shawn Izadi never made it out of the Moncrief-Neuhaus Athletic Center.

Hed pack sheets and pillows, workout gear for the morning training session, and prepare to sleep on a couch inside the complex attached to Royal-Memorial Stadium.

Study sessions for the walk-on linebacker-slash-Longhorn Band saxophonist-slash-biochemistry major might stretch to 1:30 a.m. Those evenings, hed glance at the clock with weary eyes and calculate how much time remained before the morning alarm blared about three and a half hours.

I would just maximize every minute instead of having to walk back home and walk back to Moncrief, Izadi said. I was like, I could save myself 30, 40 minutes, get some sleep and be ready to go in the morning.

By his own admission, Izadi was truly a crazy person.

The Coppell native and 2014 UT graduate didnt originally plan to play football for Mack Brown. Izadi gave up the game as a high school sophomore. Chosen as the bands drum major going into his junior year, he decided to pour his extracurricular efforts into that and abandon a game he still loved.

By spring of his sophomore year, Izadi got an idea. Even with band duties and one of UTs most demanding majors consuming time, he missed the game.

I thought, you know, if Im going to play for any team, it might as well be the best team in the country, Izadi said. The first time I tried out I didnt take myself seriously. I really wasnt prepared from a conditioning standpoint, weight training standpoint. I was just a band nerd at that time. And so of course that ended exactly the way you think its gonna end.

Izadis first tryout was a disaster. The result remains seared into his memory body depleted, corpse-like, crumpled up in a pile of sweat and vomit. Drained of everything save his will to try again.

He went out again the following fall. Better this time, but not enough.

Izadi still hadnt reached his breaking point by the time spring tryouts commenced in 2012. By then, the strength and conditioning staff recognized the face. They could hardly believe the biochem band nerd was back for more punishment.

They were like, Again? Are we gonna have to kill him for a third time? Izadi quipped. And luckily I was in pretty good shape. I wasnt keeling over. And gladly they saw something to take a chance on me.

Still upright and breathing after the third try, Izadi found his name listed among the new walk-ons on a sign posted outside Moncrief. That day felt like a dream.

He floated through the athletic center, in awe of the memorabilia on display, the legends commemorated on plaques and busts. Izadi was part of it now.

I saw my name, and I almost didnt believe it, Izadi confessed. I was like, Is this correct? Because I wasnt expecting I was just naturally you know, keeping my expectations low. This is gonna sound cheesy, but I actually teared up a little bit.

The team gave Izadi a locker next to Jordan Hicks, a high school All-American who went on to win Super Bowl LII as a member of the Philadelphia Eagles. So the saxophonist and future medical student set up shop next to the 2015 NFL draft pick who now plays for the Arizona Cardinals.

About two hours after he was accepted to the Texas football team, Izadi had to scramble to get over to band practice. Somehow, over the next two years, he managed the juggling act.

Izadi suited up for home games and traveled with the band for road trips. He never missed practice for either.

In fact, Brown and the rest of the staff had no idea one of their players was pulling double duty until they traveled to the Cotton Bowl in October 2013 for the Red River Showdown.

We were marching in and Coach Brown looked at me, Izadi recalled. He was like, Is that Shawn? The entire coaching staff is like, Shawn Azadi, whats he doing with a saxophone and a Stetson cowboy hat on?

They just literally went haywire on the sidelines. I think that was actually probably the greatest part for me.

Izadi never appeared in a game. Didnt matter. The experience, the grind and the battle to earn his helmet, was enough.

After graduating he spent a year working at Irvings Abbott Laboratories then returned to football in 2015 as a graduate assistant and coaching intern at North Texas. Brown helped him secure the gig.

All the while, he was waiting on an acceptance letter from University of Texas Rio Grande Valley (UTRGV) School of Medicine.

Its really interesting because looking back it I dont even know if at that time I really had direction, Izadi said. But I knew that I loved football. I knew that I loved medicine. I knew that I wanted to be in one of those fields.

Good news arrived during the season. Izadi enrolled at UTRGV in July 2016 and graduated this spring.

Next week, hell move out to Portland, Ore., to begin training at Oregon Health and Science University for general surgery. It could last five to seven years, two more if Izadi opts to become either a pediatric surgeon or a trauma critical care surgeon.

To most, that sounds like a nightmare. For Izadi, its simply another challenge.

Once I set my mind toward something, Izadi said, Im not going to quit until I get it.

nmoyle@express-news.net

Twitter: @NRmoyle

Go here to see the original:
Former UT walk-on linebacker recalls juggling band practice, and biochemistry - San Antonio Express-News

Mynomx Pioneers the Personalization Science of Food Nutrition to Prevent and Fight Onset of COVID-19 – Business Wire

PALO ALTO, Calif.--(BUSINESS WIRE)--Mynomx Inc. (formerly Precision Wellness, Inc.), a Silicon Valley-based company at the intersection of next-generation AI analytics and the latest medical and nutrition science, today announced their personalized nutrition approach to boosting cardio and metabolic health for disease prevention and immune system support.

The Novel Coronavirus (COVID-19) has swept the world and struck those with underlying cardiometabolic syndrome: inflammation, hypertension, obesity, diabetes, and cardiovascular disorders, the hardest. The incidence and prevalence of people with cardiometabolic syndromes are on the rise, with over 40% of the US population suffering from one form of cardiovascular disease, posing the greatest burden as the nation's costliest chronic disease and number one killer.

It is clear a new approach to prevention is needed and one that involves proper nutritional interventions. Mynomx focuses on preventing the onset and progression of cardiovascular and metabolic disorders, using food as medicine, through an AI-driven personalized nutrition approach designed to each person's unique metabolism, biochemistry, health, and genetics.

"Expression of our genetic blueprint works hand-in-hand with our nutritional consumption to define our metabolism. The food that we eat directly affects the biochemical pathways that may result in a metabolic imbalance within every tissue and cell, including those of our immune system", explains Dr. Mehrdad Rezaee, Interventional Cardiologist at Cardiac and Vascular Care, a clinical scientist and a Mynomx co-founder.

The Mynomx personalized nutrition approach is predicated on AI health predictive and food recommendation engines designed from the ground up to improve balance across those cardio and metabolic pillars of health that prevent the onset of inflammation, hypertension, obesity, dyslipidemia, and diabetes.

According to Dr. Rezaee, "Achieving metabolic balance leads to an efficient metabolism which is associated with increased energy levels, optimal weight, and a bolstered immune system that can remove toxins, fight bacteria and viruses, and help in preventing the onset and severity of disease, as well as the recovery from injuries."

Unlike other food platforms that only score the quality of food without the knowledge of a person's true state of health, Mynomx's personalized nutrition platform connects food, nutrition, and health at the molecular level to provide precision nutrition food scoring and recommendations based on a person's unique biology and health.

Each person's unique health and biochemistry requires different nutrients, restrictions, and sensitivities that define their personalized dietary pattern. Mynomx combines this pattern with an individual's preference, to produce a curated list of foods ranked based on this precision nutrition score.

"We believe we can profoundly improve the health of our communities through actionable health insights and recommendations that use food-as-medicine personalized to bolster each person's metabolic response," explains Mynomx CEO Nazhin Zarghamee.

Mynomx AI applies this food scoring to whole foods, meals, packaged foods, restaurants, and recipes, to allow for healthy choices at the point of food shopping, meal selection, and meal planning decision making. Food retailers can use the Mynomx platform to build deeper personalization and engagement applications.

Mynomx's outcome-driven approach is predicated around nutritional guidelines and patterns designed to boost metabolic functioning and fight COVID-19. Government and self-insured organizations can use Mynomx predictive analytics to understand the at-risk population and deliver personalized nutrition programs to drive population health, ensuring the health of our communities.

Mynomx health predictions (previously Precision Wellness) have been validated with the highest levels of accuracy across 2.8M patient populations in conjunction with leading institutions such as Stanford Medicine [or University] & Broad Institute (a Harvard, MIT, Massachusetts General Hospital Collaborative). Reference Publication.

About Mynomx

Mynomx is a leading scientific food personalization company that offers organizations and individuals an advanced, integrative approach to managing their health through personalized health insights and nutritional intervention. The data-driven Mynomx analytic platform, powered by the latest in nutritional science at the molecular level, multi-omics, and next-generation AI, offers the means to manage health through "food as medicine," preventing disease and supporting healthy aging. In addition to serving individuals, our platform is ideal for insurance and self-insured organization, corporate wellness, testing, and diagnostic companies as well as food retailers who are seeking deeper personalization and engagement. To learn more, visit http://www.mynomx.com.

Go here to see the original:
Mynomx Pioneers the Personalization Science of Food Nutrition to Prevent and Fight Onset of COVID-19 - Business Wire

NIH funding supports research on first therapeutic drug to regenerate heart tissue – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.May 29 2020

With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic drug that can regenerate heart tissue. The lesion-seeking biological drug, released through stent placement, could treat coronary blockages and prevent heart failure.

Currently, there are no viable therapeutics available on the market that can promote regeneration of the heart to prevent myocardial infarction, or heart attack. All available medicines treat only symptoms to slow the onset of heart failure. The design of our biologics improves current methods of controlled release, because it takes advantage of specific biochemical events that occur during heart failure."

Josh Sakon, professor of biochemistry in the J. William Fulbright College of Arts and Sciences

Biologics, or biological drugs, are pharmaceutical products made from or containing components of living organisms. Used in biotechnology, biologics include a variety of products taken from humans, animals or microorganisms.

Sakon received $30,000 from the NIH - and a matching gift from the Commercialization Fund, a subset of the U of A Chancellor's Fund - to develop and commercialize sFGF1, a human "fibroblast growth factor" designed by Suresh Thallapuranam, professor of biochemistry. Fibroblast growth factors are cell-signaling proteins involved in a variety of processes critical to normal physiological development. Irregularities in the function of these proteins lead to a range of developmental defects.

Thallapuranam and Kartik Balachandran, associate professor of biomedical engineering, are part of Sakon's team focused on developing the drug. They are working on fusing sFGF1 with a different, collagen-binding protein released through stents, the thin mesh tubes that a heart surgeon inserts into arteries and blood vessels to relieve blockage and promote tissue healing. As Sakon mentioned, the advantage of their drug is that it functions in accordance with specific biochemical activity that occurs leading up to and during an adverse event.

In addition to funding drug development, the NIH award will help the researchers obtain intellectual property and pursue critical safety and feasibility assessments, including toxicity and biocompatibility testing in both lab and animal studies. Their results will be used to secure Small Business Technology Transfer funding for preclinical efficacy studies before seeking approval from the U.S. Food and Drug Administration. The NIH funding will also help the researchers identify a potential drug carrier.

The researchers' project is one of seven biomedical innovations funded by the NIH via XLerateHealth and its affiliate, the Southeast XLerator Network, which is led by the University of Kentucky. The award is part of the network's Ideas to Products program that supports researchers with competitive proof-of-concept funding that will help accelerate healthcare technologies for commercialization.

With 24 academic institutions, the Southeast XLerator Network was created to support the commercialization of promising life science and healthcare innovation in several southeastern states and Puerto Rico. Its program goal is to broaden the geographic distribution of NIH funding and to help accelerate early-stage biomedical technology from laboratory to market, with an emphasis on supporting geographically underserved areas in healthcare.

According to the American Heart Association, more than 600,000 Americans experience a new myocardial infarction each year, with 275,000 deaths attributable to heart failure. About one in four patients who survive an initial heart attack develop heart failure within four years of the initial first heart attack. Rapid diagnosis and intervention after a coronary blockage can significantly improve chances of patient survival.

Original post:
NIH funding supports research on first therapeutic drug to regenerate heart tissue - News-Medical.Net

2020 Current trends in Automatic Veterinary Biochemistry Analyzer Market Share, Growth, Demand, Trends, Region Wise Analysis of Top Players and…

Automatic Veterinary Biochemistry Analyzer Market 2020: Latest Analysis

Chicago, United States: The global Automatic Veterinary Biochemistry Analyzer Market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. Report Hive Researchs latest publication, titled global Automatic Veterinary Biochemistry Analyzer market, offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the global Automatic Veterinary Biochemistry Analyzer market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market. The Automatic Veterinary Biochemistry Analyzer market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

This study covers following key players: Biochemical Systems InternationalBPC BioSedCarolina Liquid ChemistriesAbaxis EuropeAMS AllianceRandox LaboratoriesRayto Life and Analytical SciencesScil Animal CareCrony InstrumentsDiaSys Diagnostic SystemsEurolyser DiagnosticaGesan ProductionHeskaIdexx LaboratoriesLITEON IT CorporationShenzhen Icubio Biomedical TechnologyURIT Medical Electronic

To know How COVID-19 Pandemic Will Impact This Market/Industry | Get the Sample of this Report with Detail TOC and List of [emailprotected]

NOTE: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Automatic Veterinary Biochemistry Analyzer Market which would mention How the Covid-19 is Affecting the Automatic Veterinary Biochemistry Analyzer Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Automatic Veterinary Biochemistry Analyzer Players to Combat Covid-19 Impact.

The research report covers the trends that are currently implemented by the major manufacturers in the Automatic Veterinary Biochemistry Analyzer market including adoption of new technology, government investments on R&D, shifting in perspective towards sustainability, and others. Additionally, the researchers have also provided the figures necessary to understand the manufacturer and its contribution to both regional and global market:

The Essential Content Covered in the Global Automatic Veterinary Biochemistry Analyzer Market Report :

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Market segment by Type, the product can be split into:

Bench-Top Veterinary Biochemistry AnalyzerPortable Veterinary Biochemistry Analyzer

Market segment by Application, split into:

Pet HospitalVeterinary Station

The report answers important questions that companies may have when operating in the global Automatic Veterinary Biochemistry Analyzer market. Some of the questions are given below:

What will be the size of the global Automatic Veterinary Biochemistry Analyzer market in 2025? What is the current CAGR of the global Automatic Veterinary Biochemistry Analyzer market? Which product is expected to show the highest market growth? Which application is projected to gain a lions share of the global Automatic Veterinary Biochemistry Analyzer market? Which region is foretold to create the most number of opportunities in the global Automatic Veterinary Biochemistry Analyzer market? Will there be any changes in market competition during the forecast period? Which are the top players currently operating in the global Automatic Veterinary Biochemistry Analyzer market? How will the market situation change in the coming years? What are the common business tactics adopted by players? What is the growth outlook of the global Automatic Veterinary Biochemistry Analyzer market?

The scope of the Report:

The report segments the global Automatic Veterinary Biochemistry Analyzer market on the basis of application, type, service, technology, and region. Each chapter under this segmentation allows readers to grasp the nitty-gritties of the market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the market. It also address political scenarios that are expected to impact the market in both small and big ways.The report on the global Automatic Veterinary Biochemistry Analyzer market examines changing regulatory scenario to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Get Customized PDF template of this report: https://www.reporthive.com/request_customization/2311706

There are 15 Chapters to display the Automatic Veterinary Biochemistry Analyzer Market Research.

Chapter 1, to describe Definition, Specifications and Classification of Automatic Veterinary Biochemistry Analyzer , Applications of Automatic Veterinary Biochemistry Analyzer , Market Segment by Regions;

Chapter 2, to analyze the Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;

Chapter 3, to display the Technical Data and Manufacturing Plants Analysis of Automatic Veterinary Biochemistry Analyzer , Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;

Chapter 4, to show the Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis;

Chapter 5 and 6, to show the Regional Market Analysis that includes North America, Europe, Asia-Pacific etc., Automatic Veterinary Biochemistry Analyzer Segment Market Analysis;

Chapter 7 and 8, to analyze the Automatic Veterinary Biochemistry Analyzer Segment Market Analysis (by Application) Major Manufacturers Analysis of Automatic Veterinary Biochemistry Analyzer;

Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type, Market Trend by Application;

Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;

Chapter 11, to analyze the Consumers Analysis of Automatic Veterinary Biochemistry Analyzer;

Chapter 12, to describe Automatic Veterinary Biochemistry Analyzer Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describe Automatic Veterinary Biochemistry Analyzer sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Speak to Research Analyst: +1-312-604-7084

About Us:Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of United States Business Leaders, Government Organizations, SMEs, Individual and Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio and application analysis etc.

Continued here:
2020 Current trends in Automatic Veterinary Biochemistry Analyzer Market Share, Growth, Demand, Trends, Region Wise Analysis of Top Players and...

Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.May 27 2020

Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.

Finding drugs that can inhibit the infection caused by SARS-CoV-2 is an essential step to finding the vaccine that can definitively bring the spread of the virus to an end.

In this regard, the URV's Cheminformatics and Nutrition research group has carried out a computational screening to predict whether there is a medicine authorised for treating another pathology that can inhibit the main protease of the virus (M-pro).

This is key to the whole process because this enzyme plays an essential role in the replication of the virus.

The study demonstrates that a human and a veterinary anti-inflammatory drug - Carprofen and Celecoxib - inhibit a key enzyme in the replication and transcription of the virus responsible for COVID-19.

The aim of the study was to use computer techniques to analyze whether 6,466 drugs authorized by various drug agencies for both human and veterinary use could be used to inhibit the M-pro enzyme.

This enzyme is a protease that is responsible for cutting two polypeptides (generated by the virus itself) and generating a number of proteins that are essential for the reproduction of the virus.

Some of the trials coordinated by the WHO against the COVID-19 pandemic also aim to inhibit M-pro using two antiretrovirals such as Lopinavir and Ritonavir (drugs initially designed to treat HIV).

As a result of the study conducted at the URV, it has been predicted that 7 of these 6,466 drugs may inhibit M-pro.

The results have been shared with the international initiative COVID Moonshot which has selected 2 of these 7 compounds (i.e., Carprofen and Celecoxib) in order to test their ability to inhibit M-pro in vitro.

The results obtained show that at a concentration of 50 M of Celecoxib or Carprofen, the inhibition of the in vitro activity of M-pro is 11.90 and 4.0%, respectively. Therefore, both molecules could be used as a starting point for further lead optimization to obtain even more potent derivatives.

The study by the Cheminformatics and Nutrition research group from the Biochemistry and Biotechnology Department of the URV has been led by Drs. Gerard Pujadas and Santi Garcia-Vallv with the collaboration of Drs. Aleix Gimeno, Mara Jos Ojeda-Montes and Adri Cereto-Massagu, the PhD students Guillem Macip and Bryan Saldivar-Espinoza and student Jlia Mestres-Truyol (double degree student in Biotechnology and in Biochemistry and Molecular Biology at the URV).

It has been published by the International Journal of Molecular Sciences (IJMS) and is the first to be published worldwide on drug repositioning as inhibitors of SARS-CoV-2 M-pro where computational predictions are experimentally corroborated.

The remaining 5 molecules are expected to be selected soon by COVID Moonshot so that their bioactivity can be tested as well.

Source:

Journal reference:

Gimeno A. et al. (2020) Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. International Journal of Molecular Sciences. doi.org/10.3390/ijms21113793.

See more here:
Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection - News-Medical.Net

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of…

NEW YORK, May 29, 2020 /PRNewswire/ -- The global veterinary point-of-care diagnostics market is projected to grow at a CAGR of 8.9% during the forecast year.

Read the full report: https://www.reportlinker.com/p05902706/?utm_source=PRN

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%. The increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for rapid disease detection are the major factors driving the growth of this market. However, the high cost of veterinary imaging instruments is expected to restrain market growth to a certain extent.

The consumables segment dominates the veterinary point-of-care diagnostics market." Based on product, the veterinary point-of-care diagnostics market is segmented into consumables and instruments. Consumables accounted for the largest market share in 2018. The large share of the consumables segment can be attributed to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases, and growth in the companion animal population worldwide. This segment is also expected to grow at the highest CAGR during the forecast period.

By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018.On the basis of technology, the veterinary point-of-care diagnostic kits & analyzers market has been segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and other technologies.The clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostic kits & analyzers market in 2018.

The higher preference for advanced clinical diagnostic products by veterinarians and pet owners and the wide applications of this technology are contributing to the large share of this market.

The Asia Pacific market to witness the highest growth during the forecast period.The Asia Pacific market is expected to witness the highest growth during the forecast period, primarily due to the rapidly increasing animal population, growing adoption of veterinary diagnostic products, and rising demand for animal-derived food products.

Breakdown of primary participants is as mentioned below: By Company Type: Tier 1: 35%, Tier 2: 40%, and Tier 3: 25% By Designation: C-level: 35%, Director-level: 25%, and Others: 40% By Region: North America: 35%, Europe: 30%, Asia Pacific: 15%, Middle East and Africa: 10%, and Latin America: 10%

Prominent players in the veterinary point-of-care diagnostics market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories Ltd. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Research Coverage:The report analyzes the veterinary point-of-care diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments, such as product, technology, application, animal type, end user, and region.It also covers competitive leadership mapping, which helps in analyzing the position of key market players as visionary leaders, innovators, dynamic players, and emerging players.

The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the ReportThe report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers: Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary point-of-care diagnostics market. The report analyzes this market by product, technology, application, animal type, end user, and region. Product Enhancement/Innovation: Detailed insights on upcoming trends and launches in the global veterinary point-of-care diagnostics industry Market Development: Comprehensive information on the lucrative emerging markets by product, application, animal, end user, technology, and region Market Diversification: Exhaustive information about new testing services, growing geographies, recent developments, and investments in the global veterinary point-of-care diagnostics industry Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, and capabilities of leading players in the global veterinary point-of-care diagnostics market

Read the full report: https://www.reportlinker.com/p05902706/?utm_source=PRN

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Read more:
The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of...

Couple on the coronavirus front lines – UCI News

Naptime is over.

Ilhem Messaoudi Powers, associate professor of molecular biology & biochemistry at UCI, is enjoying a rare weekend at home with her husband, Dr. Michael Powers, when they hear the rustling of their two young children.

He bounds up the stairs to retrieve Owen, 3, and Olivia, 6 months, from a Saturday afternoon slumber. Soon the living room is full of the joyous noises of a toddler and an infant.

When theyre not wearing their mommy and daddy hats, Ilhem and Michael Powers are exploring and immersing themselves in an entirely different world: the COVID-19 pandemic.

A virologist and immunologist, Ilhem Powers leads a team of researchers whove launched a surveillance study of UCI Health workers to determine how many have antibodies against the coronavirus.

Michael Powers is a pulmonologist who works as a critical care doctor at the Naval Medical Center San Diego, caring for patients with COVID-19, as well as others.

Because of his unpredictable schedule, he often stays for days at an apartment in San Diego while his wife, with the assistance of a part-time nanny, juggles kids and career from the couples on-campus home and her laboratory.

Mike and I have been through a lot together, she says. Weve really learned to focus on the now.

Indeed, her husband was just two weeks into medical school at New Orleans Tulane University when Hurricane Katrina hit in late August of 2005. Ilhem Powers had accepted a job at the school as an assistant professor and was getting ready to relocate from their previous home in Portland, Oregon.

The New Orleans duplex that the couple had renovated with most of their savings wound up under 8 feet of water. It took them more than a year to recover.

One of the biggest lessons Ive learned in life is to focus on the things you have some control over, Michael Powers says. You just have to let go of the rest.

Surveillance study

Ilhem Powers lab cohort have pivoted from their usual work to conduct COVID-19 research as members of UCIs Institute for Immunology and Center for Virus Research.

Their surveillance study, funded by a $60,000 UCI grant and expected to last a year, will repeatedly examine 300 healthcare providers. The collection of samples has already begun.

We want to know how many of them may have already been exposed [to COVID-19] and didnt know about it and how many of them potentially have immunity, Ilhem Powers says. Well take blood samples and nose swabs to measure antibodies and T cell responses, which kill infected cells, as well as potential asymptomatic shedding. Its a multipronged approach.

Arriving at UCI in January 2017 after serving as a researcher and assistant professor at UC Riversides School of Medicine, she has years of experience studying how the human immune system interacts with emerging viral diseases such as Ebola, Chikungunya, Zika and monkeypox.

For some viruses, Ilhem Powers explains, antibodies are sufficient [to kill them]. For others, you need more of a T cell response. We dont yet know enough about this novel coronavirus.

More community surveillance needs to be done, she says: How many people have potential COVID-19 antibodies? We also need to look at the immune response in patients those currently in hospitals and then determine the difference between the immune response of those who end up in the ICU versus those who end up being sent home.

Health scare

Michael Powers, who began his residency at the Naval Medical Center San Diego in 2010, says the COVID-19 pandemic has forced him and other doctors to live with a lot of uncertainty.

But he has a stoic air about him despite his relatively new role of treating patients with a little-understood disease. Perhaps experiencing a serious lung-related health scare himself contributes to his even-keeled nature.

During his wifes last year at UC Riverside, Michael Powers went on an outreach mission to Ghana. Shortly after returning home, he developed MRSA in his lungs and had to undergo thoracic surgery. He spent 10 days in the hospital and 30 days in convalescence.

It was a pulmonologists worst nightmare, Ilhem Powers says. It was really scary.

So is COVID-19, her husband says: I think a lot of people have a very romanticized notion of what ICU-level care is and being on a ventilator. The movies definitely dont do it justice.

When people go on ventilators, its not at all uncommon for them to be on them for two weeks or more. Its not a pleasant thing to have a giant plastic tube down your throat and a machine telling you when to breathe.

Enjoying the little moments

Michael Powers says he takes extreme precautions at work and elsewhere in San Diego before driving up to Irvine to spend time with his wife and children.

People ask me all the time, Isnt he worried? Ilhem Powers says. They ask, Shouldnt he just stay in his apartment and not come up here and pose a health risk to you and your kids? And we just say we understand and accept the risk.

She and her colleagues get tested regularly for COVID-19 using equipment in their lab.

Having already weathered a lot of adversity, the couple believe theyre uniquely equipped to cope with COVID-19.

What we both do for a living, and our past experience dealing with crises, has put us in this perfect position to deal with this pandemic, he says.

For many people, she adds, this is the first time that things outside their control have completely dominated their life.

Often, the two will sit down and go over COVID-19 research papers together and compare notes, discussing where the pandemic is headed, possible therapies and longer term potential vaccines.

But they make sure that when theyre together, they shower most of their attention on Owen and Olivia.

When hes home, Ilhem Powers says of her husband, its family time. For us, its all about enjoying the little moments.

Read the original here:
Couple on the coronavirus front lines - UCI News

According to Latest Report on Dicyandiamide (CAS 461-58-5) Market to Grow with an Impressive CAGR Shandong Efirm Biochemistry, Ningxia Baoma Chemical…

Dicyandiamide (CAS 461-58-5) Market Research Report 2020 With COVID-19 Analysis

The global market report is a systematic research of the global Dicyandiamide (CAS 461-58-5) Market portraying the current state of affairs in the market. Further, it offers an estimation of the market measure as far as esteem and in volume and discusses the key fragments and the topographical subdivisions of the market for Dicyandiamide (CAS 461-58-5) advertise in subtle elements.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/14729

Key Competitors of the Global Dicyandiamide (CAS 461-58-5) Market are: , AlzChem, NCI, Denka, Jiafeng Chemical, Ningxia Sunnyfield Chemical, Darong Group, Gulang Xinmiao, Yinglite Chemical, Beilite Chemical, Shandong Efirm Biochemistry, Ningxia Baoma Chemical

The fundamental purpose of Dicyandiamide (CAS 461-58-5)Market report is to provide a correct and strategic analysis of the Dicyandiamide (CAS 461-58-5) industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

It gives top to bottom instructive information on the advancement patterns and the approaches and controls, concerning Dicyandiamide (CAS 461-58-5) showcase, actualized in every one of the topographical sections. The dominating utilizations of this market have additionally been talked about finally in this exploration consider.

Major Product Types covered are: , Calcium Cyanamide Granular, Calcium Cyanamide Powder

Major Applications of Dicyandiamide (CAS 461-58-5) covered are: , Fertilizer Industry, Pesticide Industry, Others

To get this report at a profitable rate.: https://reportsinsights.com/discount/14729

What are the affecting elements that are made reference to in the report?

Market Scenario:The report further highlights the development trends in the global Dicyandiamide (CAS 461-58-5) market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Key Market Highlights:The Dicyandiamide (CAS 461-58-5) report gives a top to bottom examination on a portion of the key elements, involving income, cost, limit, limit usage rate, creation, generation rate, utilization, import/send out, supply/request, net, piece of the pie, CAGR, and gross edge. Furthermore, the report shows a far reaching investigation of the market development factors and their most recent patterns, alongside important market fragments and sub-portions.

Analytical Tools:The Global Dicyandiamide (CAS 461-58-5) Market report incorporates the decisively examined and assessed information of the significant market members and their market scope utilizing various investigative devices. The diagnostic apparatuses incorporate Porters five powers examination, SWOT investigation, achievability study, and venture return investigation, which have been utilized to consider the development of the key players working in the market.

The main points which are answered and covered in this Report are-

What will be the total Dicyandiamide (CAS 461-58-5) Market in the coming years till 2026?What will be the key factors which will be overall affecting the industry?What are the various challenges addressed?Which are the major companies included?

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Dicyandiamide-CAS-461-58-5-Market-14729

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:info@reportsinsights.com

Sales:sales@reportsinsights.com

Originally posted here:
According to Latest Report on Dicyandiamide (CAS 461-58-5) Market to Grow with an Impressive CAGR Shandong Efirm Biochemistry, Ningxia Baoma Chemical...